The intriguing inverse relationship between the expression of TSC22D3, which encodes GILZ, and that of TYR, which encodes TYROSINASE, a melanoma differentiation marker as well as a strong tumour antigen, suggests that GILZ may prevent MeSC differentiation, thereby diminishing melanoma immunogenicity. The gene discussed is TSC22D3; the disease is neoplasm.